Canada markets closed

CRISPR Therapeutics AG (CRSP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
53.91+0.18 (+0.34%)
At close: 04:00PM EDT
54.11 +0.20 (+0.37%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.58B
Enterprise Value 3.12B
Trailing P/E 124.34
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.54
Price/Book (mrq)2.43
Enterprise Value/Revenue 8.44
Enterprise Value/EBITDA -15.40

Trading Information

Stock Price History

Beta (5Y Monthly) 1.74
52-Week Change 39.84%
S&P500 52-Week Change 322.36%
52 Week High 391.10
52 Week Low 337.55
50-Day Moving Average 370.89
200-Day Moving Average 359.46

Share Statistics

Avg Vol (3 month) 31.73M
Avg Vol (10 day) 31.33M
Shares Outstanding 584.88M
Implied Shares Outstanding 684.88M
Float 878.84M
% Held by Insiders 11.86%
% Held by Institutions 169.11%
Shares Short (Apr 15, 2024) 414.74M
Short Ratio (Apr 15, 2024) 411.42
Short % of Float (Apr 15, 2024) 419.70%
Short % of Shares Outstanding (Apr 15, 2024) 417.37%
Shares Short (prior month Mar 15, 2024) 414.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -41.38%
Operating Margin (ttm)34.58%

Management Effectiveness

Return on Assets (ttm)-6.22%
Return on Equity (ttm)-8.17%

Income Statement

Revenue (ttm)371.21M
Revenue Per Share (ttm)4.69
Quarterly Revenue Growth (yoy)3,353,333.20%
Gross Profit (ttm)N/A
EBITDA -202.7M
Net Income Avi to Common (ttm)-153.61M
Diluted EPS (ttm)-1.94
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.69B
Total Cash Per Share (mrq)21.1
Total Debt (mrq)238.63M
Total Debt/Equity (mrq)12.67%
Current Ratio (mrq)17.54
Book Value Per Share (mrq)23.52

Cash Flow Statement

Operating Cash Flow (ttm)-260.38M
Levered Free Cash Flow (ttm)-238.97M